Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis

논문상세정보
' Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • procalcitonin
  • prognosis
  • sepsis
  • soluble suppression of tumorigenicity 2
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,168 0

0.0%

' Soluble ST2 Has a Prognostic Role in Patients With Suspected Sepsis' 의 참고문헌

  • http://www.accessdata.fda.gov/cdrh_docs/reviews/k111452.pdf
  • Update on procalcitonin measurements
    Meisner M Ann Lab Med 34 : 263 ~ 273 [2014]
  • Update on Procalcitonin Measurements
    Michael Meisner Annals of Laboratory Medicine 34 4 263-273 [2014]
  • The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine
    Vincent JL Intensive Care Med 22 : 707 ~ 710 [1996]
  • The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine
    Vincent JL Intensive Care Med 22 707-710 [1996]
  • The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2
    Mueller T Expert Rev Mol Diagn 13 : 13 ~ 30 [2013]
  • The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2
    Mueller T Expert Rev Mol Diagn 13 13-30 [2013]
  • Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012
    Dellinger RP Intensive Care Med 39 165-228 [2013]
  • Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012
    Dellinger RP Intensive Care Med 39 : 165 ~ 228 [2013]
  • Soluble ST2 plasma concentrations predict mortality in severe sepsis
    Hoogerwerf JJ Intensive Care Med 36 : 630 ~ 637 [2010]
  • Soluble ST2 plasma concentrations predict mortality in severe sepsis
    Hoogerwerf JJ Intensive Care Med 36 630-637 [2010]
  • Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality
    Parenica J Exp Clin Cardiol 17 : 205 ~ 209 [2012]
  • Soluble ST2 levels in patients with cardiogenic and septic shock are not predictors of mortality
    Parenica J Exp Clin Cardiol 17 205-209 [2012]
  • Soluble ST2 in ambulatory patients with heart failure : Association with functional capacity and long-term outcomes
    Felker GM Circ Heart Fail 6 : 1172 ~ 1179 [2013]
  • Soluble ST2 in ambulatory patients with heart failure : Association with functional capacity and long-term outcomes
    Felker GM Circ Heart Fail 6 1172-1179 [2013]
  • Soluble ST2 and galectin-3 in heart failure
    Shah RV Clin Lab Med 34 : 87 ~ 97 [2014]
  • Soluble ST2 and galectin-3 in heart failure
    Shah RV Clin Lab Med 34 87-97 [2014]
  • Serum levels of procalcitonin as a biomarker for differentiating between sepsis and systemic inflammatory response syndrome in the neurological intensive care unit
    Tian G J Clin Neurosci 21 : 1153 ~ 1158 [2014]
  • Serum levels of procalcitonin as a biomarker for differentiating between sepsis and systemic inflammatory response syndrome in the neurological intensive care unit
    Tian G J Clin Neurosci 21 1153-1158 [2014]
  • ST2 protein in heart disease: from discovery to mechanisms and prognostic value
    Weinberg EO Biomark Med 3 : 495 ~ 511 [2009]
  • ST2 protein in heart disease: from discovery to mechanisms and prognostic value
    Weinberg EO Biomark Med 3 495-511 [2009]
  • Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
    Wacker C Lancet Infect Dis 13 : 426 ~ 435 [2013]
  • Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
    Wacker C Lancet Infect Dis 13 426-435 [2013]
  • Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis
    Kim H Clin Biochem 46 : 1414 ~ 1418 [2013]
  • Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis
    Kim H Clin Biochem 46 1414-1418 [2013]
  • Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department
    Di Somma S Clin Chem Lab Med 51 : 1167 ~ 1175 [2013]
  • Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department
    Di Somma S Clin Chem Lab Med 51 1167-1175 [2013]
  • Long-term mortality and quality of life in sepsis: a systematic review
    Winters BD Crit Care Med 38 : 1276 ~ 1283 [2010]
  • Long-term mortality and quality of life in sepsis: a systematic review
    Winters BD Crit Care Med 38 1276-1283 [2010]
  • Laboratory detection of sepsis: biomarkers and molecular approaches
    Riedel S Clin Lab Med 33 : 413 ~ 437 [2013]
  • Laboratory detection of sepsis: biomarkers and molecular approaches
    Riedel S Clin Lab Med 33 413-437 [2013]
  • Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection
    Alves-Filho JC Nat Med 16 : 708 ~ 712 [2010]
  • Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection
    Alves-Filho JC Nat Med 16 708-712 [2010]
  • Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma
    Brunner M Intensive Care Med 30 : 1468 ~ 1473 [2004]
  • Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma
    Brunner M Intensive Care Med 30 1468-1473 [2004]
  • Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction
    Weinberg EO Circulation 106 : 2961 ~ 2966 [2002]
  • Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction
    Weinberg EO Circulation 106 2961-2966 [2002]
  • Establishment of reference intervals for soluble ST2 from a United States population
    Lu J Clin Chim Acta 411 : 1825 ~ 1826 [2010]
  • Establishment of reference intervals for soluble ST2 from a United States population
    Lu J Clin Chim Acta 411 1825-1826 [2010]
  • Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care?
    Schuetz P Curr Opin Crit Care 18 : 341 ~ 349 [2012]
  • Do sepsis biomarkers in the emergency room allow transition from bundled sepsis care to personalized patient care?
    Schuetz P Curr Opin Crit Care 18 341-349 [2012]
  • Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis
    Hur M BMC Infect Dis 14 : 224 ~ [2014]
  • Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis
    Hur M BMC Infect Dis 14 224- [2014]
  • Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma-the Presage ST2 assay
    Dieplinger B Clin Chim Acta 409 : 33 ~ 40 [2009]
  • Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma-the Presage ST2 assay
    Dieplinger B Clin Chim Acta 409 33-40 [2009]
  • American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    Yancy CW J Am Coll Cardiol 62 : e147 ~ 239 [2013]
  • American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    Yancy CW J Am Coll Cardiol 62 e147-239 [2013]